Prognostic factors in patients with node-negative gastric carcinoma: A comparison with node-positive gastric carcinoma

Table 2 Histopathologic features of node-negative and -positive gastric carcinoma

Variables	Node-negative(n = 1524) (%)	Node-positive(n = 1324) (%)	P value
Tumor size (mean, cm)	2.9 ± 2.0	5.0 ± 2.7	< 0.001
Location			NS
Upper	123 (8.1)	141 (10.7)
Middle	443 (29.0)	358 (27.0)
Lower	946 (62.1)	783 (59.1)
Whole	12 (0.8)	42 (3.2)
Macroscopic appearance			NS
EGC
Elevated	161 (20.0)	27 (24.1)
Depressed	572 (71.2)	69 (61.6)
Flat	71 (8.8)	16 (14.3)
Borrmann type			< 0.001
1	47 (6.5)	54 (4.5)
2	183 (25.4)	218 (18.0)
3	441 (61.3)	812 (67.0)
4	49 (6.8)	128 (10.5)
Depth of invasion			< 0.001
T1	804 (52.8)	112 (8.5)
T2	343 (22.5)	170 (12.8)
T3	338 (22.1)	856 (64.7)
T4	39 (2.6)	186 (14.0)
Hepatic metastasis			< 0.001
H (-)	1,519 (99.7)	1,269 (95.8)
H (+)	5 (0.3)	55 (4.2)
Peritoneal dissemination			< 0.001
P (-)	1,509 (99.0)	1,179 (89.0)
P (+)	15 (1.0)	145 (11.0)
Histologic type			<0.001
Well-differentiated	355 (23.3)	165 (12.5)
Moderately differentiated	352 (23.1)	339 (25.6)
Poorly differentiated	536 (35.1)	642 (48.5)
Signet ring cell	189 (12.4)	59 (4.5)
Mucinous	53 (3.5)	95 (7.1)
Others	39 (2.6)	24 (1.8)
Stage			<0.001
I	1,145 (75.1)	91 (6.9)
II	324 (21.3)	124 (9.4)
III	30 (2.0)	689 (52.0)
IV	25 (1.6)	420 (31.7)

NS, not significant